A naukri.com initiative
Bioengineer
6d
335
Image Credit: Bioengineer
Acetate Metabolism Emerges as Critical Defender of Brain Function in Sleep-Disrupted States
- A novel set of discoveries about acetate, a short-chain fatty acid (SCFA), has begun to illuminate how the body may deploy a protective response in the face of chronic sleep disruption.
- By examining a chronic sleep fragmentation mouse model, researchers discovered that the accumulation of acetate in the hypothalamus is not merely a by-product of dysregulated metabolism, but rather an adaptive response that can help safeguard the body from the full brunt of fragmented sleep’s deleterious effects.
- The consequences of this two-week period of sleep fragmentation proved striking. The SF mice exhibited impaired glucose metabolism, insulin resistance, and a range of metabolic alterations typically linked to disorders such as type 2 diabetes.
- Intriguingly, these systemic and brain-centered metabolic disturbances were accompanied by comprehensive changes in the circulating metabolome, especially with regard to short-chain fatty acids. SCFAs such as acetate, propionate, and butyrate rose significantly in the plasma of mice experiencing chronic sleep fragmentation.
- Oral supplementation with acetate to mice subjected to chronic sleep fragmentation yielded multiple improvements: better glucose handling, enhanced insulin sensitivity, and significant gains in cognitive tests. These improvements were mirrored by reversing the detrimental impact of antibiotics that suppressed acetate production by gut bacteria.
- Moreover, direct infusions of acetate into the central nervous system via intracerebroventricular delivery curtailed inflammation and improved metabolic and cognitive outcomes, highlighting a clear causal link between hypothalamic acetate levels and resilience to SF-induced ailments.
- The broader implications for human health are substantial. Sleep fragmentation is not only a characteristic of OSA, but it also occurs in shift workers, in many older adults experiencing age-related sleep changes, and in individuals with chronic conditions such as neurodegenerative diseases.
- If indeed acetate represents an adaptive mechanism to defend against insulin resistance and cognitive decline, therapeutic interventions might be designed to modulate acetate production, distribution, or utilization in targeted ways.
- The complexity of bridging the gap between lab-based findings and clinical practice also includes ensuring that interventions that elevate acetate or alter astrocyte function do not produce unintended consequences in other organs or systems.
- Despite the positive perspective offered by these insights, the fundamental message remains that chronic sleep fragmentation is detrimental, and the best preventive measure is, of course, to prioritize good quality sleep.
Read Full Article
20 Likes
For uninterrupted reading, download the app